Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03426059 · ClinicalTrials.gov registry record
Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
A clinical trial of Autism Spectrum Disorder and Intellectual Disability, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 24
- Enrollment target
- 6
- Study locations
NCT03426059 is a study of Autism Spectrum Disorder and Intellectual Disability that has completed, run by Boston Children's Hospital. The registered enrollment target is 24 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (82% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT03426059, a study of Autism Spectrum Disorder and Intellectual Disability, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
- 6
- Study locations
Study Summary
The protocol aims to comprehensively define the phenotype of Phelan-McDermid Syndrome and to identify potential genetic factors, which may play a role in the variability of the disease's outcomes. The first aim involves a physical exam, a neurological exam, collection of medical history information, a clinical genetic evaluation, blood work and neuropsychological assessments. If clinically indicated, the protocol collects information from medical tests. These medical tests may include electrocardiography, echocardiography, renal ultrasonography, and renal ultrasound.
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (6)
California
- Stanford University - Stanford
Illinois
- Rush University Medical Center - Chicago
Maryland
- National Institutes of Health - Bethesda
Massachusetts
- Boston Children's Hospital - Boston
New York
- Icahn School of Medicine at Mount Sinai - New York
Texas
- University of Texas Southwestern - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-05-22 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03426059
The ClinicalTrials.gov registry entry for NCT03426059 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (82% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT03426059 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Illinois, Maryland.
Frequently Asked Questions
What is clinical trial NCT03426059 about?
NCT03426059 is a clinical study titled "Mapping the Phenotype in Adults With Phelan-McDermid Syndrome". The protocol aims to comprehensively define the phenotype of Phelan-McDermid Syndrome and to identify potential genetic factors, which may play a role in the variability of the disease's outcomes. The first aim involves a physical exam, a neurological exam, collection of medical history information,...
What is the current status of trial NCT03426059?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2018-05-22. Estimated completion is 2020-12-31.
What conditions does trial NCT03426059 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Intellectual Disability, Phelan-McDermid Syndrome.
What interventions are being tested in trial NCT03426059?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT03426059?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03426059 being conducted?
This trial has 6 study locations across California, Illinois, Maryland, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.